Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 997 of 1,261
  1. US 7745691

    Genetically modified mouse lacking diacylglycerol acyltransferase-1 (DGAT-1) activity

    The Regents of the University of California · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  2. US 7745623

    Cyclic amide derivative, and its production and use

    Takeda Pharmaceutical Company Limited · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  3. US 7745708

    Self-assembly of peptide-amphiphile nanofibers under physiological conditions

    Northwestern University · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  4. US 7745569

    Amyloid specific binding peptides and detecting abeta peptide

    The Regents of the University of California · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  5. US 7745489

    Compositions and methods for inhibition of phospholipase A2 mediated inflammation

    The Regents of the University of California · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  6. US 7745418

    Compositions and methods for inhibiting viral replication

    Alnylam Pharmaceuticals, Inc. · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  7. US 7745468

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  8. US 7745416

    Method for in vivo regulation of cardiac muscle contractility

    The Regents of the University of California · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  9. US 7745407

    Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin

    The Regents of the University of California · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  10. US 7744861

    Multi-arm polymer prodrugs

    Nektar Therapeutics · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  11. US 7744902

    Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  12. US 7744934

    Methods for modulating eicosanoid metabolism

    The Board of Regents of the University of Texas System · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  13. US 7745388

    Peptides for activation and inhibition of δPKC

    The United States of America as represented by NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  14. US 7745406

    Fibroblast growth factor (FGF23) polypeptides

    Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  15. US 7745212

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  16. US 7745401

    Antifungal peptides and methods of use thereof

    The Board of Regents of the University of Oklahoma · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  17. US 7744931

    Methods for treating oral cancers with herbal compositions

    The Board of Regents of the University of Texas System · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  18. US 7745608

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  19. US 7745629

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  20. US 7745444

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted
  21. US 7741304

    Casein kinase 2 antisense therapy

    Regents of the University of Minnesota · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted
  22. US 7741321

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted
  23. US 7740889

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted
  24. US 7741431

    Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof

    The United States of America as represented by the Secretary of the Army · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.